Connect with Hemanext virtual booth at the 36th International Congress of Society of Blood Transfusions (ISBT). Learn about: Blood quality and potential impact on transfusion outcomes Potential benefits of hypoxic storage Hemanext’s vision to create a world with fewer, better transfusions Highlights: See Hemanext’s Processing System in action! View Hemanext’s accepted ISBT Abstracts Explore information […]

Hemanext is a privately held medical technology company dedicated to improving the quality, safety, efficacy, and cost of transfusion therapy. The company’s research and development efforts center on the study of hypoxically stored red blood cells (RBCs).LEARN ABOUT BLOOD QUALITY:Educational SymposiumsKey Abstracts and PublicationsPatient Advocacy GroupsRECENT NEWS: AABB RISE AWARDHemanext CONGRATULATES THE AUTHORS OF THE […]